Skip to content
Real estate activities
KZActiveBIN 020240006019
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "ДАРЬЯЛ-МЕД"

Director
Курмангалиев Равиль Талгатович
Incorporated
20.02.2002
Address
Восточно-Казахстанская область ул. НОВАТОРОВ, 2/1
РНН
181600212832

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ДАРЬЯЛ-МЕД"
BIN
020240006019
Status
Active
Director
Курмангалиев Равиль Талгатович
Registration date
20.02.2002
Activity
Аренда и управление собственной торговой недвижимостью и многофункциональными комплексами в торговой деятельности
Legal address
Восточно-Казахстанская область ул. НОВАТОРОВ, 2/1
VAT payer
No, deregistered 07.06.2017
КАТО
631010000
РНН
181600212832
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.

Has changed

Procurement role
Поставщик

Activities

1
68204primary

Аренда и управление собственной торговой недвижимостью и многофункциональными комплексами в торговой деятельности

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
792.7K
2025
580.9K-29%
2024
817.8K+223%
2023
253.4K-17%
2022
307K-7%
2021
330.5K
·792.7K
2026year to date
-29%580.9K
2025
+223%817.8K
2024
-17%253.4K
2023
-7%307K
2022
·330.5K
2021
2026
Tax paid792,671 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid580,850 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid817,802 ₸
Penalty53,965 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid253,449 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid307,000 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid330,490 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • КР

    Курмангалиев Равиль Талгатович

    Director

Former directors

  • КДКУРМАНГАЛИЕВА ДАРЬЯ НИКОЛАЕВНА
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "ДАРЬЯЛ-МЕД" (BIN 020240006019) is an active legal entity in Восточно-Казахстанская область, registered in 2002 (24 years on the market). Primary activity — аренда и управление собственной торговой недвижимостью и многофункциональными комплексами в торговой деятельности. Per open government registries as of November 10, 2026: 30 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 9,771,436 ₸. Automated screening of open registries found no risk indicators for "ДАРЬЯЛ-МЕД". Director on record — Курмангалиев Равиль Талгатович. Data current as of November 10, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.